Penelope was just three days old when she was diagnosed with Spinal Muscular Atrophy (SMA). During pregnancy, her parents had learned through genetic testing that they were both carriers, so they made sure every provider involved in her care was aware. Although she showed no immediate symptoms at birth, they were already connected with a neurologist and preparing for next steps.
While waiting for insurance approval for gene therapy, they began noticing subtle weakness in Penelope’s arms, legs, and neck. Then the long-awaited call came—treatment was approved. On St. Patrick’s Day, at just 24 days old, Penelope received life-changing gene therapy. Since that day, she has continued to grow stronger, surprising and inspiring her family with each new milestone.
